EU drug regulator to review use of Eli Lilly Mounjaro in multi-dose pen
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-02-20 08:00 GMT | Update On 2024-03-22 09:44 GMT
Frankfurt: The European Union's healthcare regulator will this week review the use of Eli Lilly's approved Mounjaro drug against diabetes and obesity when prefilled in a multi-dose injection pen, according to a meeting agenda posted on the watchdog's website on Monday.
The U.S. drugmaker won EU approval for the weekly injection late last year and has initially made starter doses available in member states Germany and Poland packaged in vials, so that patients need to draw the medication into syringes before injection.
Lilly's "Kwikpen", a multi-dose injection device that is good for four weekly subcutaneous shots, will be considered as a new route of administration for Mounjaro in a meeting of an expert panel of the European Medicines agency, according to the agenda.
Lilly has previously said European approval of the pen injector could come by the middle of the year.
Britain last week became the first major market where Mounjaro was launched in the four-week Kwikpen.
Original news source: https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drug-regulator-review-lillys-mounjaro-multi-dose-pen-2024-02-19/
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd